In the current study, we examine the combined treatment of Ras inhibitor, FTS, and Gal-3 inhibitor, MCP on anaplastic thyroid carcinoma cells (ARO) in vitro and in vivo. This evidence concerns the gene LGALS3 and thyroid gland undifferentiated (anaplastic) carcinoma.